SeluDex: A phase IB/II open label study of the MEK-inhibitor selumetinib in combination with dexamethasone for paediatric and adult patients with 2nd relapsed precursor B- or T-ALL

Project Details

Short titleSeluDex: A phase IB/II open label study of the MEK-inhibitor selumetinib in combination with dexamethasone for paediatric and adult patients with 2nd relapsed precursor B- or T-ALL
StatusActive
Effective start/end date1/10/1631/12/23

Funding

  • INNOVATIVE THERAPIES FOR CHILDREN WITH CANCER (ITCC)
  • ASTRA ZENECA UK LIMITED
  • Cancer Research Uk

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.